|
Delayed
Bombay S.E.
08:03:03 11/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 30.31 INR | +0.73% |
|
-2.51% | -36.40% |
| Market Cap | 1.07B 11.19M 9.64M 9.13M 8.27M 15.52M 15.6M 108M 41.69M 544M 42.02M 41.1M 1.72B | P/E 2025 |
-22.5x | P/E 2026 | -8.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.33B 13.95M 12.02M 11.38M 10.32M 19.36M 19.45M 135M 51.99M 678M 52.4M 51.25M 2.14B | EV / Sales 2025 |
14.5x | EV / Sales 2026 | 4.45x |
| Free-Float |
25.69% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +0.73% | ||
| 1 week | -2.51% | ||
| Current month | -4.66% | ||
| 1 month | -10.83% | ||
| 3 months | +4.66% | ||
| 6 months | -10.14% | ||
| Current year | -36.40% |
| 1 week | 29.5 | 31.7 | |
| 1 month | 29.2 | 34.79 | |
| Current year | 25.6 | 50.9 | |
| 1 year | 25.6 | 66 | |
| 3 years | 25.6 | 87.46 | |
| 5 years | 10.17 | 87.46 | |
| 10 years | 2.15 | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 09/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 75 | 05/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.73% | -2.51% | -47.52% | -17.75% | 11.19M | ||
| -0.65% | -2.93% | +47.70% | +86.30% | 994B | ||
| -0.29% | -3.51% | +49.15% | +61.95% | 640B | ||
| +0.83% | +0.26% | +17.76% | +70.10% | 454B | ||
| +4.50% | +1.22% | +37.44% | +37.89% | 337B | ||
| +2.62% | -8.69% | +17.30% | +25.57% | 261B | ||
| +2.46% | -0.48% | +4.99% | +10.82% | 246B | ||
| -1.34% | -13.70% | +36.53% | +46.70% | 204B | ||
| +1.67% | -6.09% | -20.94% | -58.89% | 190B | ||
| -0.75% | -4.82% | +25.46% | +85.90% | 178B | ||
| Average | +1.10% | -5.43% | +16.79% | +34.86% | 350.48B | |
| Weighted average by Cap. | +0.98% | -4.42% | +32.34% | +55.09% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 194M 2.04M 1.75M 1.66M 1.51M 2.82M 2.84M 19.72M 7.58M 98.94M 7.64M 7.48M 313M | 279M 2.92M 2.51M 2.38M 2.16M 4.05M 4.07M 28.28M 10.87M 142M 10.96M 10.72M 448M |
| Net income | -108M -1.13M -972K -920K -834K -1.56M -1.57M -10.93M -4.2M -54.83M -4.24M -4.14M -173M | -117M -1.23M -1.06M -1M -907K -1.7M -1.71M -11.88M -4.57M -59.61M -4.61M -4.5M -188M |
| Net Debt | 399M 4.17M 3.6M 3.41M 3.09M 5.79M 5.82M 40.45M 15.55M 203M 15.68M 15.33M 641M | 264M 2.76M 2.38M 2.25M 2.04M 3.83M 3.85M 26.78M 10.3M 134M 10.38M 10.15M 424M |
Employees
127
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | INR 30.31 | +0.73% | 774 |
| 10/09/26 | INR 30.09 | -0.40% | 10,648 |
| 09/09/26 | INR 30.21 | +0.23% | 4,297 |
| 08/09/26 | INR 30.14 | -0.56% | 12,512 |
| 07/09/26 | INR 30.31 | -2.51% | 13,277 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
















